Kanada - angličtina - Health Canada

sanis health inc - midodrine hydrochloride - tablet - 5mg - midodrine hydrochloride 5mg

Jihoafrická republika - angličtina - South African Health Products Regulatory Authority (SAHPRA)

allergan -

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

juno pharmaceuticals nz limited - tazarotene 0.5 mg/g - topical cream - 0.5 mg/g - active: tazarotene 0.5 mg/g excipient: benzyl alcohol carbomer carbomer 934p disodium edetate dihydrate light liquid paraffin medium-chain triglycerides purified water sodium hydroxide sodium thiosulfate pentahydrate sorbitan oleate - for the topical treatment of plaque psoriasis.

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

juno pharmaceuticals nz limited - tazarotene 1 mg/g - topical cream - 1 mg/g - active: tazarotene 1 mg/g excipient: benzyl alcohol carbomer carbomer 934p disodium edetate dihydrate light liquid paraffin medium-chain triglycerides purified water sodium hydroxide sodium thiosulfate pentahydrate sorbitan oleate - for the topical treatment of plaque psoriasis.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - metformin hydrochloride, quantity: 500 mg - tablet, modified release - excipient ingredients: colloidal anhydrous silica; magnesium stearate; povidone; hypromellose - treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. metformin modified release tablets may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - metformin hydrochloride, quantity: 1000 mg - tablet, modified release - excipient ingredients: hypromellose; povidone; magnesium stearate; colloidal anhydrous silica - treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. metformin modified release tablets may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - metformin hydrochloride -

Kanada - angličtina - Health Canada

bristol-myers squibb canada - captopril - tablet - 25mg - captopril 25mg - angiotensin-converting enzyme inhibitors

Kanada - angličtina - Health Canada

bristol-myers squibb canada - captopril - tablet - 50mg - captopril 50mg - angiotensin-converting enzyme inhibitors

Kanada - angličtina - Health Canada

bristol-myers squibb canada - captopril - tablet - 100mg - captopril 100mg - angiotensin-converting enzyme inhibitors